155 related articles for article (PubMed ID: 33798738)
21. A pocket-sized disposable device for testing the integrity of sensation in the outpatient setting.
Bowling FL; Abbott CA; Harris WE; Atanasov S; Malik RA; Boulton AJ
Diabet Med; 2012 Dec; 29(12):1550-2. PubMed ID: 22672290
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic.
Olaleye D; Perkins BA; Bril V
Diabetes Res Clin Pract; 2001 Nov; 54(2):115-28. PubMed ID: 11640995
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study.
Santos TRM; Melo JV; Leite NC; Salles GF; Cardoso CRL
J Diabetes Complications; 2018 Aug; 32(8):770-776. PubMed ID: 29950276
[TBL] [Abstract][Full Text] [Related]
24. Choosing a Vibratory Test to Pair With Semmes Weinstein Monofilament Testing for Evaluating Lower Extremity Sensation in Patients With Diabetes: A Comparison of Three Vibratory Methodologies.
Raymond B; Steriovski J; Gillyard K; Yang C; Wu SC; Crews RT
J Diabetes Sci Technol; 2020 Jan; 14(1):8-15. PubMed ID: 31113243
[TBL] [Abstract][Full Text] [Related]
25. Interprofessional Validation of the Ipswich Touch Test in Adults With Diabetes: The Canadian Experience.
McLaren AM; Lu SH
Can J Diabetes; 2023 Feb; 47(1):38-42. PubMed ID: 36050256
[TBL] [Abstract][Full Text] [Related]
26. Can the 128-Hz tuning fork be an alternative to the biothesiometer for diabetic peripheral neuropathy screening? A cross-sectional study in a tertiary hospital in East India.
Chattopadhyay S; Goswami S; Sengupta N; Baidya A
BMJ Open; 2024 Jun; 14(6):e082193. PubMed ID: 38862223
[TBL] [Abstract][Full Text] [Related]
27. Comparison of sensory testing on different toe surfaces: implications for neuropathy screening.
Dimitrakoudis D; Bril V
Neurology; 2002 Aug; 59(4):611-3. PubMed ID: 12196660
[TBL] [Abstract][Full Text] [Related]
28. The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population-based sample of people with known and newly detected diabetes in Barbados: a cross-sectional study.
Adams OP; Herbert JR; Howitt C; Unwin N
Diabet Med; 2019 Dec; 36(12):1629-1636. PubMed ID: 31094005
[TBL] [Abstract][Full Text] [Related]
29. Monofilament assessment of neuropathy in a community diabetes clinic.
Rheeder P; van Wyk JT; Hokken JW; Hueting HM
S Afr Med J; 2002 Sep; 92(9):715-9. PubMed ID: 12382357
[TBL] [Abstract][Full Text] [Related]
30. Difficulties in screening for peripheral neuropathies in children with diabetes.
Hirschfeld G; von Glischinski M; Knop C; Wiesel T; Reinehr T; Aksu F; Blankenburg M; Hirsch J; Zernikow B
Diabet Med; 2015 Jun; 32(6):786-9. PubMed ID: 25640325
[TBL] [Abstract][Full Text] [Related]
31. Comparison of vibration perception thresholds obtained with the Neurothesiometer and the CASE IV and relationship to nerve conduction studies.
Bril V; Perkins BA
Diabet Med; 2002 Aug; 19(8):661-6. PubMed ID: 12147147
[TBL] [Abstract][Full Text] [Related]
32. MICRO-CONTROLLED THERMAL STIMULATOR FOR DETECTING FINE FIBER CHANGES IN PATIENTS WITH DIABETES MELLITUS: A DIAGNOSTIC ACCURACY STUDY.
Paixão JC; de Oliveira FR; Guimarães NS; Machado JAN; de Souza MRCP
Prim Care Diabetes; 2021 Jun; 15(3):548-553. PubMed ID: 33541822
[TBL] [Abstract][Full Text] [Related]
33. Non-invasive assessment of vibration perception and protective sensation in people with diabetes mellitus: inter- and intra-rater reliability.
Lanting SM; Spink MJ; Tehan PE; Vickers S; Casey SL; Chuter VH
J Foot Ankle Res; 2020; 13():3. PubMed ID: 31988664
[TBL] [Abstract][Full Text] [Related]
34. Role of neuropathy and high foot pressures in diabetic foot ulceration.
Frykberg RG; Lavery LA; Pham H; Harvey C; Harkless L; Veves A
Diabetes Care; 1998 Oct; 21(10):1714-9. PubMed ID: 9773736
[TBL] [Abstract][Full Text] [Related]
35. A novel robotic monofilament test for diabetic neuropathy.
Wilasrusmee C; Suthakorn J; Guerineau C; Itsarachaiyot Y; Sa-Ing V; Proprom N; Lertsithichai P; Jirasisrithum S; Kittur D
Asian J Surg; 2010 Oct; 33(4):193-8. PubMed ID: 21377106
[TBL] [Abstract][Full Text] [Related]
36. Easier operation and similar power of 10 g monofilament test for screening diabetic peripheral neuropathy.
Zhang Q; Yi N; Liu S; Zheng H; Qiao X; Xiong Q; Liu X; Zhang S; Wen J; Ye H; Zhou L; Li Y; Hu R; Lu B
J Int Med Res; 2018 Aug; 46(8):3278-3284. PubMed ID: 29808737
[TBL] [Abstract][Full Text] [Related]
37. Tuning fork (128 Hz) versus neurothesiometer: a comparison of methods of assessing vibration sensation in patients with diabetes mellitus.
O'Neill J; McCann SM; Lagan KM
Int J Clin Pract; 2006 Feb; 60(2):174-8. PubMed ID: 16451290
[TBL] [Abstract][Full Text] [Related]
38. Is it possible to substitute the monofilament test for the Ipswich Touch Test in screening for peripheral diabetic neuropathy?
Dutra LMA; Moura MC; do Prado FA; De Oliveira Lima G; Melo MC; Fernandez RNM; Novaes MRCG
Diabetol Metab Syndr; 2020; 12():27. PubMed ID: 32266011
[TBL] [Abstract][Full Text] [Related]
39. Screening and prevalence of peripheral neuropathy in type 2 diabetic outpatients: a randomized multicentre survey in 12 city hospitals of China.
Liu F; Bao Y; Hu R; Zhang X; Li H; Zhu D; Li Y; Yan L; Li Y; Lu J; Li Q; Zhao Z; Ji Q; Jia W
Diabetes Metab Res Rev; 2010 Sep; 26(6):481-9. PubMed ID: 20661939
[TBL] [Abstract][Full Text] [Related]
40. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements.
McGill M; Molyneaux L; Spencer R; Heng LF; Yue DK
Diabetes Care; 1999 Apr; 22(4):598-602. PubMed ID: 10189538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
